Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer have?
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer has 166 citations in the OpenAlex counts ScholarIQ stores.
When was Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer published?
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer has 2020 year in the ScholarIQ index.
What is the open-access status of Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer?
Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer has gold oa status in the ScholarIQ index.
What is the DOI of Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer?
The DOI for Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer is on the source record.
What is the PMID of Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer?
The PMID for Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer is on the source record.
What is the OpenAlex record for Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer?
The OpenAlex for Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer is on the source record.